The Practice Guidelines Committee (PGC) is pleased to announce publication updates for three NSGC clinical guidance documents:
The Telehealth Systematic Evidence Review (SER) is an especially significant milestone—it is NSGC’s first published SER. An SER is a criterion for all NSGC practice guidelines and helps inform recommendations within the associated practice guideline. NSGC’s development process for practice guidelines requires separate and distinct author groups to conduct a topic’s SER and its practice guideline. The Telegenetics Practice Guideline author group is making great progress—look for more updates on the practice guideline document soon.
NSGC congratulates and thanks the Telegenetics SER author group:
- Noelle Danylchuk
- Lola Cook
- Kate Shane-Carson
- Cara Cacioppo
- Melanie Hardy
- Rachel Nusbaum
- Susan Steelman
- Jennifer Malinowski
The Consanguinity Focused Revision is an addendum to NSGC’s Consanguinity Practice Resource, Genetic Counseling and Screening of Consanguineous Couples and their Offspring, and provides additional guidance in accordance with updated literature.
NSGC congratulates and thanks the Consanguinity Focused Revision author group:
- Robin Bennett
- Neeraja Reddy
- Peter Byers
- Robert Steiner
- Kim Barr
The Clinical Documentation Practice Resource is an original manuscript resulting from NSGC’s initiatives to provide guidance to help genetic counselors increase efficiency and work at the top of their scope of practice. The Resource provides evidence-informed best practices for clinical documentation to help genetic counselors effectively communicate among patients, practitioners, facilities and payers.
NSGC congratulates and thanks the Clinical Documentation Practice Resource author group:
- Katherine Hunt Brendish
- Devanshi Patel
- Kristen Yu
- Chelsea Alexander
- Jennifer Lemons
- Andrew Gunter
- Erin Carmany
The Journal of Genetic Counselors published each of the above manuscripts online. They are available to all NSGC members.
NSGC’s PGC has several practice resources in various stages development:
- Lynch Syndrome
- Pedigree Nomenclature
- Polygenic Risk Scores
- Proactive Genetic Screening Tests
Each of these documents undergo PGC review, peer review, NSGC member comment, NSGC Ethics Advisory Group review, NSGC Legal review and NSGC Board review. Look for updates on each document in the coming months.
The PGC is also facilitating five clinical practice guideline efforts that are either in the SER or guideline phase:
- Expanded Carrier Screening
- Hereditary Cancer
- Hypertrophic Cardiomyopathy
NSGC could not develop these documents without the engagement and support of the NSGC membership. If you are interested in helping NSGC develop practice documents, stop by the PGC’s page on NSGC's website to learn more about various ways to get involved with the Committee—as a member, an author or a proposal submitter. Look for an announcement in September about the Committee’s 2022 application process.